Elacridar-d 4 (Major)

Overview

Elacridar -d 4 (Major) is the deuterium labeled Elacridar ( HY-50879 ). Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein ( BCRP ) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer .

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > BCRP | Products > Signaling Pathways > P-glycoprotein

Product Information

• Catalog No.: HY-W777317
• CAS No.: 1189481-51-3
• Molecular Formula: C34H29D4N3O5
• Molecular Weight: 567.67
• Purity: 99.98%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source